Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.74 |
| ▸ | MEN1 | O00255 | 5/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.74 |
| ▸ | USP2 | O75604 | 1/20 | 0.74 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.74 |
| ▸ | EGFR | P00533 | 2/20 | 0.69 |
| ▸ | PIM1 | P11309 | 1/20 | 0.69 |
| ▸ | RAB9A | P51151 | 6/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.68 |
| ▸ | NPC1 | O15118 | 2/20 | 0.66 |
| ▸ | ELANE | P08246 | 4/20 | 0.61 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.61 |
| ▸ | POLB | P06746 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.61 |
| ▸ | FGB | P02675 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | PPARG | P37231 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31435387 | 0.94 | MAPT (0.70) | MAPTMEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL3417492 | 0.94 | EGFR (0.76) | MAPTMEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL9264626 | 0.92 | MAPT (0.74) | MAPTMEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL8947495 | 0.92 | EGFR (0.73) | MAPTMEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL7792566 | 0.90 | EGFR (0.71) | MAPTMEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL10974170 | 0.88 | EGFR (0.74) | MAPTMEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL28569052 | 0.88 | MAPT (0.68) | MAPTMEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL4015824 | 0.88 | MEN1 (0.68) | MAPTMEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL29595070 | 0.86 | MAPT (0.66) | MAPTMEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL28573446 | 0.86 | MAPT (0.66) | MAPTMEN1KMT2AALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 660 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119101344-A | Laser welding polyphenyl ether alloy and preparation method thereof | 广东兴盛迪科技有限公司 | 2024-12-10 | — | — | CN | claimed |
| US-20220372355-A1 | METHOD FOR MAKING AGGLOMERATE PARTICLES | MCARDLE JAMES L (US) | 2022-11-24 | — | — | US | claimed |
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | claimed |
| US-11203706-B1 | Method for making agglomerate particles | AMERIPOLISH INC. (US) | 2021-12-21 | — | — | US | claimed |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH ZURICH (CH) | 2021-06-24 | — | — | US | claimed |
| CN-112794932-A | Method for improving enzymolysis performance of lignocellulose biomass through pretreatment | 江南大学 | 2021-05-14 | — | — | CN | claimed |
| EP-3801507-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2021-04-14 | — | — | EP | claimed |
| US-20170298209-A1 | USE OF A QUINONE COMPOUND IN BUILDING MATERIALS | ARKION LIFE SCIENCES, LLC (US) | 2017-10-19 | — | — | US | claimed |
| CN-103993364-B | A kind of method aoxidizing degumming raising ramee performance | 东华大学 | 2016-10-12 | — | — | CN | claimed |
| CN-103866950-B | Cement matrix prestressing force composite floor board and preparation method thereof | BEIHUA UNIVERSITY (CN) | 2016-04-06 | — | — | CN | claimed |
| US-20150208657-A1 | USE OF QUINONE COMPOUND IN BUILDING MATERIALS | ARKION LIFE SCIENCES, LLC (US) | 2015-07-30 | — | — | US | claimed |
| EP-1745000-A2 | NOVEL ANTHRAQUINONES AND PROCESS FOR THE PREPARATION AND METHOD OF USE THEREOF | Michigan State University (US) | 2007-01-24 | — | — | EP | claimed |
| US-20050267307-A1 | Novel anthraquinones and process for the preparation and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2005-12-01 | — | — | US | claimed |
| WO-2005113478-A2 | NOVEL ANTHRAQUINONES AND PROCESS FOR THE PREPARATION AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2005-12-01 | — | — | WO | claimed |
| US-6638356-B2 | Gypsum as the main material and an anthraquinone compound incorporated. And suppresses, over a long period of time, generation of hydrogen sulfide by the action of sulfate-reducing bacteria, when it is landfilled as waste. | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2003-10-28 | — | — | US | claimed |
| US-4351774-A | Process for the production of methoxyanthraquinones | CIBA-GEIGY AG (CH) | 1982-09-28 | — | — | US | claimed |
| EP-0010451-A1 | Process for the delignification of lignocellulosic material and products thereof | C.I.L. Inc. (CA) | 1980-04-30 | — | — | EP | claimed |
| US-4080370-A | Process for producing high purity methoxyanthraquinones | MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JA) | 1978-03-21 | — | — | US | claimed |
| CN-116635452-B | Free radically polymerizable crosslinking agent, curable composition, and adhesive therefrom | 3M INNOVATIVE PROPERTIES CO. (US) | 2026-05-26 | — | — | CN | disclosed |
| US-3953408-A | LITHOGRAPHIC PLATES | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JA) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050267307-A1 | Novel anthraquinones and process for the preparation and method of use thereof | PAH, APEH, SDHA | MAPT 3904/4885MEN1 1208/4885KMT2A 758/4885 |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | TOMM70, TOMM34, TIMM50 | MAPT 2071/4885MEN1 2055/4885KMT2A 4561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.